Search
Frontier Medicines is leveraging a chemoproteomics platform to try to build a better KRAS G12C
Chris Varma describes why hitting KRAS G12C in both its on and off state could be an improvement over existing medicines.
Mar 5, 2024
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page